including phospholipids, von Willebrand factor, and low-density lipoprotein receptor-related
protein (LRP). We have previously described a human monoclonal antibody called KM33
that blocks these interactions as well as cellular uptake by LRP-expressing cells. To
unambiguously identify the apparent" hot spot" on FVIII to which this antibody binds, we
have employed hydrogen-deuterium exchange mass spectrometry. The results showed that …